A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial

Annals of Oncology : Official Journal of the European Society for Medical Oncology
G GonzálezA Lage

Abstract

There is evidence of a relationship between epidermal growth factor (EGF) and tumor cell proliferation, such as the overexpression of EGF receptor (EGF-R) in different human tumors, which makes this system an interesting target for cancer treatment. Up to now, passive immunotherapy with monoclonal antibodies against the EGF-R has been assayed in clinics. Our approach consists of active immunotherapy with human EGF (hu-EGF). We conducted a pilot clinical trial to define the safety, toxicity and immunogenicity of vaccination with hu-EGF coupled to a carrier protein. Ten patients with histologically-proven malignant carcinomas (colon, lung, stomach and prostate) in advanced clinical stages were enrolled. Patients were immunized twice (on days 0 and 15) with hu-EGF linked to either tetanic toxoid (TT, five patients) or P64K Neisseria Meningitidis recombinant protein (P64k, five patients), intradermically, using aluminium hydroxyde as adjuvant. In both groups 60% of patients developed anti-EGF antibody titers without evidence of toxicity. Secondary reactions were very mild, limited to erythema and itching at the site of injection, which disappeared without medication. We conclude that the proposed vaccination with hu-EGF was well to...Continue Reading

References

Dec 1, 1992·Immunology Today·I R Cohen
Nov 1, 1992·Immunology Today·I R Cohen
Apr 20, 1990·Cell·A Ullrich, J Schlessinger
Jan 1, 1984·Breast Cancer Research and Treatment·R PérezA Lage
Jan 1, 1994·Breast Cancer Research and Treatment·J Baselga, J Mendelsohn
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O DassonvilleG Milano

❮ Previous
Next ❯

Citations

Jul 24, 2004·Expert Review of Anticancer Therapy·Susanne J RogersChristopher M Nutting
Sep 15, 2004·FEMS Immunology and Medical Microbiology·Sonia GonzálezRicardo Silva
Dec 6, 2005·Cancer Immunology, Immunotherapy : CII·Aillette MuletLuis Enrique Fernández
Mar 12, 2010·Expert Review of Vaccines·Olivia SimmonsJohn Nemunaitis
Jun 28, 2011·Expert Review of Respiratory Medicine·Gryssell RodriguezAgustin Lage
Apr 17, 2012·Expert Review of Anticancer Therapy·Gisela M Gonzalez MarinelloLuis E Raez
Jul 18, 2014·Current Oncology Reports·Rossana RuizLuis E Raez
May 5, 2016·Journal of Immunoassay & Immunochemistry·Javier Sánchez RamírezMarta Ayala Avila
May 6, 2016·Expert Review of Respiratory Medicine·Mariacarmela SantarpiaRafael Rosell
Jun 26, 2018·Expert Opinion on Biological Therapy·Marco TagliamentoCarlo Genova
Jul 1, 1999·American Journal of Respiratory Cell and Molecular Biology·P A Bunn
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·D ZaguryR C Gallo
Jan 2, 2003·Lab Animal·Bárbara O González NavarroRafael Martínez Castillo
Apr 7, 2005·Digestive Diseases·Jie ChenMatthias P A Ebert
Oct 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Deirdre O'MahonyMartin E Gutierrez
Jun 15, 2005·Expert Opinion on Biological Therapy·Tetsuhiro TsurumaKoichi Hirata
Dec 8, 2006·Expert Opinion on Biological Therapy·J Nemunaitis, J Nemunaitis
Sep 30, 2010·Immunotherapy·Richard Warrington
Aug 22, 2015·Expert Review of Vaccines·Tania Crombet RamosAgustin Lage Davila
Oct 17, 2013·World Journal of Surgical Oncology·Aymara Fernández LorenteAngel Raymundo Casacó Parada
Jun 4, 2015·Future Oncology·Johan VansteenkisteIsabelle Wauters
Jun 27, 2019·Current Drug Targets·Seyed Mostafa ParizadehAmir Avan
May 11, 2005·Preparative Biochemistry & Biotechnology·R MurphyA M Scott
Mar 24, 2006·FEMS Immunology and Medical Microbiology·Antonio E PérezGerardo Guillén
Feb 28, 2008·Current Opinion in Oncology·Paul Wheatley-Price, Frances A Shepherd
Mar 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elia Neninger VinagerasAgustín Lage Dávila
Sep 4, 2009·The Oncologist·Cesare GridelliPaola Claudia Sacco
Oct 15, 2008·Annual Review of Pharmacology and Toxicology·Gary T Jennings, Martin F Bachmann
Aug 22, 2012·Human Vaccines & Immunotherapeutics·Jian Y Cheng, Ratnavelu Kananathan
May 28, 2013·The Cancer Journal·Puneeth Iyengar, David E Gerber
Jun 23, 2011·Expert Review of Vaccines·Antonio RossiCesare Gridelli
Jul 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ian D DavisJonathan S Cebon
Jan 5, 2000·Seminars in Surgical Oncology·B A Tjoa, G P Murphy
Nov 30, 2004·Expert Review of Anti-infective Therapy·María G GuzmánGustavo Kourí
Jun 26, 2007·Current Oncology Reports·Carol Albright, Jennifer Garst
Mar 13, 2008·Médecine sciences : M/S·Armand BensussanDaniel Zagury
Mar 25, 2009·Journal of Immunotherapy·Elia NeningerAgustín Lage

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.